(Q39937220)

15 September 2017

ERG rearrangement metastasis patterns in locally advanced prostate cancer (English)

1 reference

15 September 2017

1 reference

12

1 reference

15 September 2017

Francesca Demichelis

10

0 references

Sven Perner

1

object named as

Sven Perner

1 reference

15 September 2017

11

David S Rickman

1 reference

15 September 2017

9

Rainer Kuefer

1 reference

15 September 2017

3

Ruhella R Hossain

1 reference

15 September 2017

5

Jack Groskopf

1 reference

15 September 2017

Maria A Svensson

2

1 reference

15 September 2017

John R Day

4

1 reference

15 September 2017

Ryan C Slaughter

6

1 reference

15 September 2017

Analee R Jarleborn

7

1 reference

15 September 2017

Matthias D Hofer

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

15 September 2017

1 reference

15 September 2017

75

1 reference

15 September 2017

4

1 reference

15 September 2017

762-767

1 reference

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Role of the TMPRSS2-ERG gene fusion in prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

A causal role for ERG in neoplastic transformation of prostate epithelium.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Evidence of independent origin of multiple tumors from patients with prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

Prognostic factors in lymph node-positive prostate cancer

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850965

A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate

2 December 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.10.010

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.10.010

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.10.010

10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.10.010

10.1016/J.UROLOGY.2009.10.010

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

20018353

1 reference